pharma news today obesity drugs glp-1 october 2025 Anti-Obesity Drug Market Outlook 2025–2032: Strong CAGR of 18.01% with USD 82.55 Billion Valuation Anti-Obesity Drugs Market Report 2025
Description
The GLP-1 Receptor Agonist market size is expected to reach $18.32 billion in 2030 at a CAGR of 5.4%, driven by rising prevalence of diabetes.
Glucose stimulates insulin release from pancreatic cells in a biphasic manner
Learn about GLP-1 drug interactions & nutrient deficiencies with Ozempic, Wegovy & Mounjaro
Check with your health insurance or your employer health program to see if it is covered
But thats what glucagon-like peptide-1 (GLP-1) receptor agonist medications, likeWegovyandOzempiccan help you do
Always follow your providers guidance and reach out with any questions or concerns
